These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Selective alpha-adrenoceptor blocking action of melperone. Jiang ZW; Liu TP Zhongguo Yao Li Xue Bao; 1988 Jul; 9(4):316-20. PubMed ID: 2904206 [No Abstract] [Full Text] [Related]
9. Additional studies on side effects of melperone in long-term therapy for 1 to 15 years in psychiatric patients. Kirkegaard A; Kirkegaard G; Geismar L; Christensen I Arzneimittelforschung; 1981; 31(4):737-40. PubMed ID: 6113835 [TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma concentration and arousal in normal subjects after single oral and parenteral doses of melperone, a butyrophenone neuroleptic. Molander L; Borgström L Psychopharmacology (Berl); 1983; 79(2-3):111-4. PubMed ID: 6133299 [TBL] [Abstract][Full Text] [Related]
11. Melperone in the treatment of iatrogenic psychosis in Parkinson's disease. Barbato L; Monge A; Stocchi F; Nordera G Funct Neurol; 1996; 11(4):201-7. PubMed ID: 8934152 [TBL] [Abstract][Full Text] [Related]
12. [Drugs as markers in identification. Detection of melperon (Buronil) in an adipoceratous corpse]. Pollak S; Vycudilik W Arch Kriminol; 1986; 178(1-2):25-34. PubMed ID: 2876693 [TBL] [Abstract][Full Text] [Related]
13. Hypothermia induced by atypical neuroleptics. Schwaninger M; Weisbrod M; Schwab S; Schröder M; Hacke W Clin Neuropharmacol; 1998; 21(6):344-6. PubMed ID: 9844790 [TBL] [Abstract][Full Text] [Related]
14. Additional studies on side effects of melperone in long-term therapy for 1-20 years in psychiatric patients. Christensen I; Geismar L; Kirkegaard A; Kirkegaard G Arzneimittelforschung; 1986 May; 36(5):855-60. PubMed ID: 2873821 [TBL] [Abstract][Full Text] [Related]
15. Anti-arrhythmic action of melperone in the dog heart in situ. Platou ES; Refsum H; Amlie JP; Landmark K Acta Pharmacol Toxicol (Copenh); 1979 Feb; 44(2):158-60. PubMed ID: 32738 [No Abstract] [Full Text] [Related]
16. Long-term neuroleptic treatment. Benefits and risks. Proceedings from a workshop, Copenhagen, 6th-7th September, 1979. Acta Psychiatr Scand Suppl; 1981; 291():1-159. PubMed ID: 6113728 [No Abstract] [Full Text] [Related]
17. [Clinical study of a new neuroleptic, R 2028 or haloanisone]. DE RYCK A Acta Neurol Psychiatr Belg; 1962 Jun; 62():589-603. PubMed ID: 14026044 [No Abstract] [Full Text] [Related]
18. The incorporation of butyrophenones and related compounds into a pharmacophore for dopamine D2 antagonists. Froimowitz M; Cody V Drug Des Discov; 1997 Aug; 15(2):63-81. PubMed ID: 9342550 [TBL] [Abstract][Full Text] [Related]
19. The effect of amantadine on neuroleptic-induced parkinsonism. Rüther E; Fussmann-Hegewald M; Eben E Act Nerv Super (Praha); 1973 May; 15(2):93. PubMed ID: 4148089 [No Abstract] [Full Text] [Related]
20. [Toxic and adverse neurologic effects of neuroleptics]. Nakayama K; Yakutsu N; Koga M Ryoikibetsu Shokogun Shirizu; 1999; (27 Pt 2):532-7. PubMed ID: 10434716 [No Abstract] [Full Text] [Related] [Next] [New Search]